Դանիա -
դանիերեն -
Lægemiddelstyrelsen (Danish Medicines Agency)
andriol 40 mg kapsler, bløde
orifarm a/s - testosteronundecanoat - kapsler, bløde - 40 mg
Դանիա -
դանիերեն -
Lægemiddelstyrelsen (Danish Medicines Agency)
triptorelin "orifarm" 11,25 mg depotinjektionsvæske, pulver og solvens til suspension
orifarm a/s - triptorelin - depotinjektionsvæske, pulver og solvens til suspension - 11,25 mg
Եվրոպական Միություն -
դանիերեն -
EMA (European Medicines Agency)
elonva
n.v. organon - corifollitropin alfa - reproductive techniques, assisted; ovulation induction; investigative techniques - køn hormoner og modulatorer af den genitale system, - controlled ovarian stimulation (cos) in combination with a gnrh antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (art) program. elonva is indicated for the treatment of adolescent males (14 to less than 18 years and older) with hypogonadotropic hypogonadism, in combination with human chorionic gonadotropin (hcg).
Եվրոպական Միություն -
դանիերեն -
EMA (European Medicines Agency)
lysodren
hra pharma rare diseases - mitotane - binyrebark-neoplasmer - antineoplastiske midler - symptomatisk behandling af avanceret (uopløselig, metastatisk eller tilbagefaldende) binyrebarkalsk carcinom. effekten af lysodren på ikke-funktionelle binyrebarkhormoner karcinom er ikke etableret.
Եվրոպական Միություն -
դանիերեն -
EMA (European Medicines Agency)
onsenal
pfizer limited - celecoxib - adenomatøs polyposis coli - antineoplastiske midler - onsenal er indiceret til reduktion af antallet af adenomatøse intestinale polypper i familiær adenomatøs polyposis (fap) som et supplement til kirurgi og yderligere endoskopisk overvågning (se afsnit 4. effekten af onsenal-inducerede reduktion af polyp byrde på risikoen for tarmkræft er ikke blevet påvist (se afsnit 4. 4 og 5.
Եվրոպական Միություն -
դանիերեն -
EMA (European Medicines Agency)
xtandi
astellas pharma europe b.v. - enzalutamide - prostatiske neoplasmer - endokrine terapi - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
Դանիա -
դանիերեն -
Lægemiddelstyrelsen (Danish Medicines Agency)
certican 0,25 mg dispergible tabletter
novartis healthcare a/s - everolimus - dispergible tabletter - 0,25 mg
Դանիա -
դանիերեն -
Lægemiddelstyrelsen (Danish Medicines Agency)
certican 0,5 mg tabletter
novartis healthcare a/s - everolimus - tabletter - 0,5 mg
Դանիա -
դանիերեն -
Lægemiddelstyrelsen (Danish Medicines Agency)
certican 0,75 mg tabletter
novartis healthcare a/s - everolimus - tabletter - 0,75 mg
Դանիա -
դանիերեն -
Lægemiddelstyrelsen (Danish Medicines Agency)
contalgin 100 mg depottabletter
mundipharma a/s - morphinsulfat - depottabletter - 100 mg